FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013430397> ?p ?o ?g. }

• W2013430397 endingPage "1435" @default.
• W2013430397 startingPage "1428" @default.
• W2013430397 abstract "Tumour growth is tightly related to new blood vessel formation, tissue remodelling and invasiveness capacity. A number of tissular factors fuel the growth of glioblastoma multiforme, the most aggressive brain neoplasm. In fact, gene array analyses demonstrated that the proapoptotic cytokine tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) inhibited mRNA expression of VEGF, along with those of matrix metalloproteinase-2 (MMP-2), its inhibitor tissue inhibitor of matrix metalloproteinases-2 (TIMP-2), as well as the tumour invasiveness-related gene secreted protein acid rich in cysteine (SPARC) in different human glioblastoma cell lines. Particularly, VEGF mRNA and protein expression and release from glioblastoma cells were also inhibited by TRAIL. The latter also exerted antimitogenic effects on human umbilical vein endothelial cells (HUVECs). With the same cells, TRAIL inhibited new vessel formation in the in vitro matrigel model, as well as it exerted powerful inhibition of blood vessel formation induced by an angiogenic cocktail administered in subcutaneous pellets in vivo in the C57 mouse. Moreover, the expression of MMP-2, its inhibitor TIMP-2 and the tumour invasiveness-related protein SPARC were effectively inhibited by TRAIL in glioblastoma cell lines. In conclusion, our data indicate that TRAIL inhibits the orchestra of factors contributing to glioblastoma biological aggressiveness. Thus, the TRAIL system could be regarded as a molecular target to exploit for innovative therapy of this type of tumour." @default.
• W2013430397 created "2016-06-24" @default.
• W2013430397 creator A5027839113 @default.
• W2013430397 creator A5030637337 @default.
• W2013430397 creator A5031245175 @default.
• W2013430397 creator A5034069975 @default.
• W2013430397 creator A5039616068 @default.
• W2013430397 creator A5051020417 @default.
• W2013430397 creator A5052350472 @default.
• W2013430397 creator A5056670940 @default.
• W2013430397 creator A5069031239 @default.
• W2013430397 date "2006-04-11" @default.
• W2013430397 modified "2023-10-08" @default.
• W2013430397 title "TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells" @default.
• W2013430397 cites W1502528873 @default.
• W2013430397 cites W151723881 @default.
• W2013430397 cites W1534492551 @default.
• W2013430397 cites W1557303431 @default.
• W2013430397 cites W1565495717 @default.
• W2013430397 cites W1574321107 @default.
• W2013430397 cites W1679229092 @default.
• W2013430397 cites W1838284135 @default.
• W2013430397 cites W1866664159 @default.
• W2013430397 cites W1971704934 @default.
• W2013430397 cites W1979476810 @default.
• W2013430397 cites W1979758455 @default.
• W2013430397 cites W1985712533 @default.
• W2013430397 cites W1992207122 @default.
• W2013430397 cites W1994360534 @default.
• W2013430397 cites W1995709950 @default.
• W2013430397 cites W2000000541 @default.
• W2013430397 cites W2000292756 @default.
• W2013430397 cites W2014380713 @default.
• W2013430397 cites W2014604539 @default.
• W2013430397 cites W2015955520 @default.
• W2013430397 cites W2022512688 @default.
• W2013430397 cites W2027334587 @default.
• W2013430397 cites W2033093399 @default.
• W2013430397 cites W2037183811 @default.
• W2013430397 cites W2038969437 @default.
• W2013430397 cites W2044976148 @default.
• W2013430397 cites W2049813036 @default.
• W2013430397 cites W2050004148 @default.
• W2013430397 cites W2055340771 @default.
• W2013430397 cites W2060285807 @default.
• W2013430397 cites W2062627489 @default.
• W2013430397 cites W2075444006 @default.
• W2013430397 cites W2075872629 @default.
• W2013430397 cites W2088050057 @default.
• W2013430397 cites W2094733513 @default.
• W2013430397 cites W2102630679 @default.
• W2013430397 cites W2104577276 @default.
• W2013430397 cites W2109388796 @default.
• W2013430397 cites W2113505777 @default.
• W2013430397 cites W2128531359 @default.
• W2013430397 cites W2133969014 @default.
• W2013430397 cites W2157603347 @default.
• W2013430397 cites W2160882187 @default.
• W2013430397 cites W2165921560 @default.
• W2013430397 cites W2168981489 @default.
• W2013430397 cites W2235549579 @default.
• W2013430397 cites W2401826697 @default.
• W2013430397 cites W2412491855 @default.
• W2013430397 cites W2479044294 @default.
• W2013430397 cites W27064955 @default.
• W2013430397 cites W29173195 @default.
• W2013430397 cites W37613957 @default.
• W2013430397 cites W4250989310 @default.
• W2013430397 doi "https://doi.org/10.1038/sj.bjc.6603092" @default.
• W2013430397 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2361261" @default.
• W2013430397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16622457" @default.
• W2013430397 hasPublicationYear "2006" @default.
• W2013430397 type Work @default.
• W2013430397 sameAs 2013430397 @default.
• W2013430397 citedByCount "54" @default.
• W2013430397 countsByYear W20134303972012 @default.
• W2013430397 countsByYear W20134303972013 @default.
• W2013430397 countsByYear W20134303972014 @default.
• W2013430397 countsByYear W20134303972015 @default.
• W2013430397 countsByYear W20134303972016 @default.
• W2013430397 countsByYear W20134303972017 @default.
• W2013430397 countsByYear W20134303972018 @default.
• W2013430397 countsByYear W20134303972019 @default.
• W2013430397 countsByYear W20134303972020 @default.
• W2013430397 countsByYear W20134303972021 @default.
• W2013430397 countsByYear W20134303972022 @default.
• W2013430397 countsByYear W20134303972023 @default.
• W2013430397 crossrefType "journal-article" @default.
• W2013430397 hasAuthorship W2013430397A5027839113 @default.
• W2013430397 hasAuthorship W2013430397A5030637337 @default.
• W2013430397 hasAuthorship W2013430397A5031245175 @default.
• W2013430397 hasAuthorship W2013430397A5034069975 @default.
• W2013430397 hasAuthorship W2013430397A5039616068 @default.
• W2013430397 hasAuthorship W2013430397A5051020417 @default.
• W2013430397 hasAuthorship W2013430397A5052350472 @default.
• W2013430397 hasAuthorship W2013430397A5056670940 @default.
• W2013430397 hasAuthorship W2013430397A5069031239 @default.
• W2013430397 hasBestOaLocation W20134303971 @default.

• next